A Case of Early Gastric Cancer with Bilateral Inguinal Lymph Node and Multiple Bone Metastases.

Kawata, Naomi; Suzuki, Yoshikazu; Saitoh, S.; Funatsu, Takashi; Kobayashi, Nobuaki

doi:10.5833/jjgs.25.2973

Cited by 4 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, synchronous hepatic metastasis was observed in 2 cases and juxta lymph node metastasis was also observed in 2 cases of EGC in the present study. Kawada et al (1992) counted a total of 16 cases of an EGC associated with n4 (+), and 10 cases of an EGC with synchronous hepatic metastasis has been reported by Ohta et al (1993).…”

Section: Discussionmentioning

confidence: 99%

Resected Early Gastric Cancer. Clinicopathological Studies on 610 Cases.

Takeda

Toyonaga

Koufuji³

et al. 1995

Kurume Med. J.

View full text Add to dashboard Cite

Summary: A total of 610 cases of early gastric cancer were studied, retrospectively.Of these, 541(88.7%) cases were single and 62 (10.1%) cases were multiple cancers.Lymph node metastasis occurred in 11.2% of the elevated, in 8.2% of the depressed and in 15.1% of the mixed type. There was no lymph node metastasis when a mucosal or submucosal cancer was less than 10 mm in diameter. By contrast, in the cases in which the preoperative diagnosis was suspected advanced cancer, the incidence of lymph node metastasis was high, at 33%. Therefore, when the preoperative diagnosis is advanced cancer, standard radical gastrectomy and/or extended radical gastrectomy should be selected even though they are found to be early gastric cancer. The age-corrected 5-year survival rate was 98.5% in the cases with no lymph node metastasis and 93.0% in the cases with lymph node metastasis (p>0.05). The 5-year survival rate was 100% in mucosal cancer and 95.5% in submucosal cancer (p>0.05).

show abstract

Section: Discussionmentioning

confidence: 99%

Resected Early Gastric Cancer. Clinicopathological Studies on 610 Cases.

Takeda

Toyonaga

Koufuji³

et al. 1995

Kurume Med. J.

View full text Add to dashboard Cite

show abstract

“…Moreover, even for the pT1a diffuse‐type carcinomas, the risk for lymph node metastases depends on the presence of ulceration (6% and 13% in non‐ulcerated vs ulcerated tumors) . The absence of lymph node metastases was assigned to carcinomas with papillary differentiation diagnosed in the pT1a , but not in the pT1b stage .…”

Section: Metastatic Behavior Of Egcmentioning

confidence: 99%

“…Although the metastatic nodes are usually located in the perigastric/extragastric areas (pN+), distant lymph nodes can also be involved and are considered distant metastases (pM1). Only 16 EGCs with distant lymph node metastases were identified in Japan till 1991 . They were predominantly identified in the para‐aortic nodes (n = 7), followed by uni/bilateral inguinal (n = 3), mesenteric (n = 1), and supraclavicular Virchow's (n = 1) lymph nodes .…”

Section: Metastatic Behavior Of Egcmentioning

confidence: 99%

“…Only 16 EGCs with distant lymph node metastases were identified in Japan till 1991 . They were predominantly identified in the para‐aortic nodes (n = 7), followed by uni/bilateral inguinal (n = 3), mesenteric (n = 1), and supraclavicular Virchow's (n = 1) lymph nodes . Additionally, axillary nodes can also be involved .…”

Section: Metastatic Behavior Of Egcmentioning

confidence: 99%

“…Only 79 cases of EGC‐related bone metastases were published between 1983 and 2015 (Table ). The cervical and thoracic vertebra were mostly affected (66–96%), followed by the ribs (40–75%), pelvis (15–44%), skull (16–30%), femur (30%), and sternum (16%) .…”

Section: Metastatic Behavior Of Egcmentioning

confidence: 99%

See 2 more Smart Citations

Aberrant metastatic behavior and particular features of early gastric cancer

Gurzu

Jung

Kádár

2015

APMIS

View full text Add to dashboard Cite

In this paper, we have focused on the metastatic behavior of EGC and its particularities. The main factors that are currently considered as predictors of the metastatic behavior and that are used in the therapeutic decision (endoscopic resection vs surgical removal) are the tumor size (upper or bellow 2 cm), depth of infiltration, angiolymphatic invasion, the presence or absence of ulceration, and histologic type (undifferentiated vs differentiated carcinomas). However, most of the metastatic cases were published as case reports or case series. This is the reason why a proper estimation of metastatic risk in EGC is not well known. To date, 79 cases presenting bone metastases, three reports of brain metastases, and one EGC that was associated with skin metastasis were published. However, occult metastasis, lymph node micrometastasis, and skip metastasis can also occur and should be identified. Making a synthesis of the literature data that is correlated with our experience, we finally proposed the inclusion of the six Japanese subgrouping system, tumor size, angiolymphatic invasion, and micrometastasis as components of the pTNM staging system, which should be particularly adapted for EGC.

show abstract